written by reader Ebola: To Parse, Perchance to Parlay

by DrKSSMDPhD | October 28, 2014 9:28 pm


Notice: Undefined variable: supress_subtitle in /home/sgumdev/public_html/wp-content/themes/sgum_2016/wpf.php on line 42

DR. KSS LOOKS AT EBOLA AND THE DRUGS TO COMBAT IT

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://sgumdev.stockgumshoe.com/2014/10/microblog-ebola-to-parse-perchance-to-parlay/


guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

1.2K Comments
Inline Feedbacks
View all comments
omcdac1
omcdac1
7 years ago

CELG has MANY MANY catalysts coming –
http://www.investorvillage.com/smbd.asp?mb=341&mn=191872&pt=msg&mid=14314216
25 partnerships with data coming from XLRN, AGIO, EPZM, OMED, and MPSFY soon…

πŸ‘ 468
πŸ‘ 47658
omcdac1
omcdac1
7 years ago
Reply to  DrKSSMDPhD

Thanks doc.
I wish i had more money to buy CELG.
One quick question AGIO is on phase 1 and still super expensive……….
I was doing some DD and found —-
Agios Pharmaceuticals (NASDAQ: AGIO ) on AG-221, a first-in-class IDH2 mutant inhibitor for advanced-stage tumors that express the IDH2 mutation. What’s so exciting about this early stage compound is that in April Agios reported in an interim analysis that three of six AG-221-treated blood cancer patients had a complete response, while six of seven evaluable patients had an objective response. Complete responses are incredibly rare for blood cancers, so Celgene and Agios may be sitting on a big winner. In a later phase 1 analysis, though, just six of 25 evaluable patients demonstrated a complete response, lasting anywhere from one to four months.

Is this the reason being strong and expensive ?

Thanks again Dr.

Add a Topic
3397
πŸ‘ 468
πŸ‘ 47658
πŸ‘ 47658
KennyG
KennyG
7 years ago

Benitec is announcing in about 10 min that a second patient is being dosed. Just ahead of the AGM

πŸ‘ 3530
πŸ‘ 47658
πŸ‘ 3530
arch1
7 years ago
Reply to  DrKSSMDPhD

DR KSS I hope my proximity has not infected you with early onset Oldtimers disease,,,,
IE Beni-cynicism.

Add a Topic
3932
πŸ‘ 7795
πŸ‘ 47658
arch1
7 years ago
Reply to  DrKSSMDPhD

DR Luv your humor and logic.

πŸ‘ 7795
KennyG
KennyG
7 years ago

Doc…try this if you dont already have it:
http://www.brrmedia.com/event/129135?popup=tue

πŸ‘ 3530
KennyG
KennyG
7 years ago
πŸ‘ 3530
sandiegojp
7 years ago

Re: GILD

According to this, short interest in GILD grew by 8.5%, for a total of 51,964,702 shares shorted in the month of October (3.3 days to cover).
http://www.wkrb13.com/markets/421587/short-interest-in-gilead-sciences-grows-by-8-5-gild/
This one talks about ACHN piggybacking on GILD.
http://www.fool.com/investing/general/2014/11/12/this-tiny-biotech-is-piggy-backing-on-gilead-scien.aspx
And this last one talks about large insider selling (a planned sale), as well as Moody’s raising Gilead’s senior unsecured credit ratings to A3 from Baa1:
Read more: Gilead Sciences Sees Large Insider Stock Sale Into Debt Offering (NASDAQ: GILD) – 24/7 Wall St. http://247wallst.com/healthcare-business/2014/11/12/gilead-sees-large-insider-stock-sale-into-debt-offering/#ixzz3ItqMjqTN

Add a Topic
899
Add a Topic
1340
Add a Topic
5971
πŸ‘ 491
πŸ‘ 1313
gumshoeben
3 years ago

Very interesting discussion of Ebola and the Epidemic that came to NYC. I actually have a method for treating an individual already infected with Ebola. Preliminary data with a safer negative-strand RNA virus in tissue culture and with Sendai virus in mice confirms that it will work. I would be interested in making some money from this idea so I won’t divulge exactly what the treatment is. However, when Dr. Craig Spencer came to NYC I emailed the NYC Public Health Dept with my idea, and never got a reply. I then emailed one of the nurses who had cared for him, whose name and email became available, and she basically replied to buzz off, she didn’t want to be bothered. Ebola has that kind of effect on people who come into contact with it. So perhaps we can Parlay on this topic, partly with a view to exchange expert knowledge on the virus, and partly to figure out how to make some $$ on it without giving the simple secret away. Note that this method is not specific for Ebola; it will work equally well against any negative-strand RNA virus, such as measles virus in Africa, and to counter the next 1919-type flu pandemic.
Benjamin M Blumberg, PhD

Add a Topic
4282
πŸ‘ 2
1 18 19 20